In vitro, exposure of CCR10-B16 cells to CCL27 led to rapid activation of Akt, which resulted in resistance of CCR10-B16 cells to cell death induced by melanoma antigen-specific cytotoxic T cells. The gene discussed is AKT1; the disease is melanoma.